Stock VOR VOR BIOPHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Vor Biopharma Inc.

Equities

VOR

US9290331084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.81 USD +0.56% Intraday chart for Vor Biopharma Inc. +5.85% -19.56%
May. 13 Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating MT
May. 09 Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating
MT
Vor Biopharma : ASGCT – 2024 – Poster Presentation 1775
PU
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
AQ
Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
AQ
Vor Bio to Participate in Upcoming Investor Conferences
AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
AQ
Vor Biopharma Inc. Appoints Fouad Namouni as Class II Director
CI
Vor Bio to Participate in Upcoming Investor Conferences
AQ
Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating
MT
Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating
MT
Vor Biopharma : Bio Corporate Presentation March 2024
PU
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
AQ
Vor Biopharma Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Vor Biopharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Vor Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
AQ
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
Vor Bio to Participate in Upcoming Investor Conferences
AQ
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VOR Stock
  4. News Vor Biopharma Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW